Bigelow Investment Advisors, LLC Gilead Sciences, Inc. Transaction History

Bigelow Investment Advisors, LLC

$203 Million
Q1 2024

A detailed history of Bigelow Investment Advisors, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Bigelow Investment Advisors, LLC holds 5,168 shares of GILD stock, worth $349,098. This represents 0.19% of its overall portfolio holdings.

Number of Shares

5,168

Previous 5,168 -0.0%

Holding current value

$349,098

Previous $418,000 9.57%

% of portfolio

0.19%

Previous 0.23%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 25, 2023	SELL	$76.01 - $86.7 $19,002 - $21,675	-250 Reduced 4.61%	5,168 $398,000
Q3 2022 Nov 10, 2022	SELL	$59.54 - $68.01 $8,752 - $9,997	-147 Reduced 2.64%	5,418 $334,000
Q2 2022 Jul 18, 2022	BUY	$57.72 - $65.01 $5,021 - $5,655	87 Added 1.59%	5,565 $344,000
Q4 2021 Feb 11, 2022	SELL	$64.88 - $73.64 $6,488 - $7,364	-100 Reduced 1.79%	5,478 $398,000
Q3 2021 Nov 04, 2021	SELL	$67.69 - $73.03 $6,430 - $6,937	-95 Reduced 1.67%	5,578 $390,000

Q2 2020 Aug 11, 2020	SELL	$72.34 - $84.0 $28,936 - $33,600	-400 Reduced 6.59%	5,673 $436,000
Q1 2020 May 05, 2020	SELL	$62.63 - $80.22 $47,911 - $61,368	-765 Reduced 11.19%	6,073 $454,000
Q4 2019 Jan 31, 2020	SELL	$61.62 - $67.78 $554 - $610	-9 Reduced 0.13%	6,838 $444,000
Q3 2019 Oct 22, 2019	SELL	$62.51 - $69.0 $29,692 - $32,775	-475 Reduced 6.49%	6,847 $434,000
Q2 2019 Jul 17, 2019	SELL	$61.87 - $69.38 $28,150 - $31,567	-455 Reduced 5.85%	7,322 $495,000
Q2 2018 Jul 19, 2018	SELL	$64.88 - $75.68 $23,486 - $27,396	-362 Reduced 4.45%	7,777 $551,000
Q1 2018 Apr 19, 2018	BUY	$72.84 - $88.8 $24,765 - $30,192	340 Added 4.36%	8,139 $614,000
Q4 2017 Feb 09, 2018	BUY	$71.15 - $83.52 $554,898 - $651,372	7,799	7,799 $559,000

Others Institutions Holding GILD

# of Institutions

1,885

Shares Held

Call Options Held

8.71M

Put Options Held

8.02M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $84.7B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bigelow Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bigelow Investment Advisors, LLC with notifications on news.

Account

Bigelow Investment Advisors, LLC Gilead Sciences, Inc. Transaction History